Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
PainLow Back PainOsteoarthritisNeuropathic Pain
Interventions
DRUG

BEMA Buprenorphine

buccal soluble film; applied to the buccal mucosa twice daily

Trial Locations (26)

Unknown

Birmingham

Mobile

Phoenix

Arcadia

Fresno

La Jolla

Long Beach

Westminster

DeLand

Jupiter

Plantation

Port Orange

Marietta

Bloomington

Evansville

Leawood

Watertown

Las Vegas

New York

Raleigh

Winston-Salem

Altoona

Austin

El Paso

Salt Lake City

West Jordan

All Listed Sponsors
lead

BioDelivery Sciences International

INDUSTRY